HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsSeroepidemiologic StudiesAntibodies, ViralAntibodies, BacterialAcquired Immunodeficiency SyndromeChlamydophila pneumoniaeImmunoglobulin GChlamydophila InfectionsPrimary PreventionPrevalenceSerologic TestsEnzyme-Linked Immunosorbent AssayHIV SeronegativityHelicobacter pyloriHelicobacter InfectionsAIDS SerodiagnosisCross-Sectional StudiesToxocariasisCytomegalovirus InfectionsHIV-1Antibodies, ProtozoanCenters for Disease Control and Prevention (U.S.)ToxoplasmosisHerpesvirus 2, HumanRisk-TakingRural PopulationUnited StatesCase-Control StudiesToxocaraBlood DonorsSecondary PreventionHepatitis CHomosexuality, MaleAge FactorsHomosexualitySexual PartnersPapillomavirus InfectionsBrazilIncidenceAnti-HIV AgentsSyphilisCohort StudiesNeosporaAIDS-Related Opportunistic InfectionsCytomegalovirusHerpes GenitalisProspective StudiesOdds RatioCD4 Lymphocyte CountToxoplasmaImmunoglobulin AProstitutionHepatitis A Virus, HumanHepatitis APregnancyHuman papillomavirus 16IndiaHepatitis BSexually Transmitted DiseasesImmunoglobulin MLogistic ModelsQuestionnaires